# Microplastics Analytical Methods and Contamination Controls > No single gold-standard method measures all MNPs. FTIR/Raman count and identify particles; Py-GC/MS reports mass; blanks are mandatory or claims are weak. *Published 2026-07-10 · Updated 2026-07-10 · By Elena Voss* In short No gold-standard single method covers all MNPs. **FTIR/Raman** = count + ID above size floors; **Py-GC/MS** = mass including nano contributions. **Blanks + LOQ** are non-optional. Never silently convert mass to counts. A zero without a method limit of detection is not clean water. It is a quiet instrument. *This article is informational and editorial only. It is not medical advice, diagnosis, or a treatment plan. Numbers and literature ranges cited here are not personal prescriptions. Consult a qualified clinician before changing medications, supplements, diet, equipment, or management of a diagnosed condition. Seek urgent care for emergencies.* ## What is the method-capability matrix? Optical spectroscopy methods identify polymers and count particles above size cutoffs. [Primpke and colleagues](https://pmc.ncbi.nlm.nih.gov/articles/PMC7680748/) compare FTIR imaging and Py-GC/MS strategies that inform multi-method designs. Py-GC/MS reports mass including nano contributions but loses shape and count. [Qian et al. 2024 PNAS](https://www.pnas.org/doi/10.1073/pnas.2300582121) pushed nanoplastic counting in bottled water with SRS imaging, showing most particles were nano-sized. SEM/TEM with EDS add morphology and elemental clues but are not polymer-specific alone. ## What contamination controls are mandatory? [Koelmans et al. 2019](https://pmc.ncbi.nlm.nih.gov/articles/PMC6449537/) critical review frameworks make QA scoring non-optional for credible water studies: blanks, positive controls, polymer ID confidence, and transparent methods. Human matrices raise the bar further because lipids and proteins interfere with pyrolysis markers. Cotton lab coats, filtered reagents, clean cabinets, and recovery spikes are boring and decisive. Plastic centrifuge tubes plus ultra-low polyethylene blanks without proof are an anti-pattern that has misled more than one viral concentration chart. Method quick map MethodOutputsKey limit µFTIRCount + polymer IDSize floor microns RamanCount + ID (smaller)Fluorescence interference Py-GC/MSPolymer massNo morphology; matrix issues SRS / advanced imagingNano-capable countsSpecialized, emerging ## How should readers interpret zeros and headline concentrations? Never interpret a zero without stating method LOD/LOQ and size cutoff. Prefer blanks, recoveries, and LOQ reporting. Do not meta-analyze FTIR water particle studies with Py-GC/MS tissue mass studies as one concentration series. Require orthogonal confirmation for landmark human claims when available. Historical microplastic-only water studies can undercount by roughly 10–100 times relative to nano-inclusive methods in some comparisons—method era is part of the number. ## What anti-patterns destroy measurement credibility? Publishing particle counts without blanks. Using plasticware while claiming ultra-low PE blanks without proof. Overclaiming polymer ID from non-specific pyrolysis markers. Ignoring differential polymer degradation during digestion that biases recovery. Method literacy is how environmental health content avoids both denialism and viral numerology. High-impact blood, plaque, and organ studies using Py-GC/MS carry high contamination-control stakes precisely because their headlines travel farthest. Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease. Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease. Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease. Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease. Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease. Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease. Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease. Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease. Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease. Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease. Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease. Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease. ## Sources 1. [Koelmans 2019 QA critical review](https://pmc.ncbi.nlm.nih.gov/articles/PMC6449537/) 2. [Primpke FTIR vs Py-GC/MS](https://pmc.ncbi.nlm.nih.gov/articles/PMC7680748/) 3. [Qian 2024 SRS nanoplastics bottled water](https://www.pnas.org/doi/10.1073/pnas.2300582121) 4. [Leslie 2022 blood Py-GC/MS](https://pubmed.ncbi.nlm.nih.gov/35367073/) --- Source: https://healthcanon.com/environmental-health/microplastics-analytical-methods-controls Index: https://healthcanon.com/llms.txt · Full text: https://healthcanon.com/llms-full.txt